نتایج جستجو برای: daclatasvir

تعداد نتایج: 714  

Journal: :The New England journal of medicine 2015
David L Wyles Peter J Ruane Mark S Sulkowski Douglas Dieterich Anne Luetkemeyer Timothy R Morgan Kenneth E Sherman Robin Dretler Dawn Fishbein Joseph C Gathe Sarah Henn Federico Hinestrosa Charles Huynh Cheryl McDonald Anthony Mills Edgar Turner Overton Moti Ramgopal Bruce Rashbaum Graham Ray Anthony Scarsella Joseph Yozviak Fiona McPhee Zhaohui Liu Eric Hughes Philip D Yin Stephanie Noviello Peter Ackerman

BACKGROUND The combination of daclatasvir, a hepatitis C virus (HCV) NS5A inhibitor, and the NS5B inhibitor sofosbuvir has shown efficacy in patients with HCV monoinfection. Data are lacking on the efficacy and safety of this combination in patients coinfected with human immunodeficiency virus type 1 (HIV-1). METHODS This was an open-label study involving 151 patients who had not received HCV...

Journal: :Genetics 1984
M Thomas-Orillard

Drosophila C virus, a picornavirus that has some influence on ovarian morphogenesis, was discovered in a French strain of Drosophila melanogaster. When the strain was infected by Drosophila C virus (DCV), the mean number of ovarian tubes and weights of the adult females increased, but the developmental time from egg to imago decreased. The maternal effects observed when DCV was present disappea...

Journal: :The Lancet. Global health 2015
Isabelle Andrieux-Meyer Jennifer Cohn Evaldo S Affonso de Araújo Saeed S Hamid

www.thelancet.com/lancetgh Vol 3 November 2015 e676 gross national income (figure). In high-income countries, the price per bottle of sofosbuvir ranged from $14 000 (Spain) to $20 590 (Switzerland). Prices for daclatasvir ranged from $1128 (South Korea) to $14 899 (Germany); those of simeprevir from $9166 (Spain) to $14 865 (Australia); those of ledipasvir-sofosbuvir from $12 604 (USA) to $24 8...

2015
Mark Mascolini

17.7. Zeuzem S, Ghalib R, Rajender Reddy K, et al.Grazoprevir–elbasvir combination therapy for treatmentnaive cirrhotic and noncirrhotic patients with chronic HCVgenotype 1, 4, or 6 infection: a randomized trial. AnnIntern Med. Published online 24 April 2015doi:10.7326/M15-0785.8. Yeh WW. Drug-drug interactions withgrazoprevir/elbasvir: practical considerations for t...

2017
Kelly D. Goodwin Luke R. Thompson Bernardo Duarte Tim Kahlke Andrew R. Thompson João C. Marques Isabel Caçador

Ocean Chemistry and Ecosystems Division, Atlantic Oceanographic and Meteorological Laboratory (stationed at NOAA/NMFS/SWFSC/La Jolla, CA), National Oceanic and Atmospheric Administration, Miami, FL, USA, Department of Biological Sciences and Northern Gulf Institute, University of Southern Mississippi, Hattiesburg, MS, USA, Marine and Environmental Sciences Centre (MARE), Faculty of Sciences, Un...

2017
Pedro F. Vale Michael D. Jardine

Infection avoidance behaviors are the first line of defense against pathogenic encounters. Behavioral plasticity in response to internal or external cues of infection can therefore generate potentially significant heterogeneity in infection. We tested whether Drosophila melanogaster exhibits infection avoidance behavior, and whether this behavior is modified by prior exposure to Drosophila C Vi...

2016
Hayato Baba Kazuto Tajiri Kohei Nagata Kengo Kawai Masami Minemura Toshiro Sugiyama

Daclatasvir (DCV) and asunaprevir (ASV) are direct-acting antivirals (DAAs) used in the treatment of chronic hepatitis C virus (HCV) infection. Combined therapy with DCV and ASV shows high efficacy and safety even in patients with cirrhosis. We encountered a patient exhibiting severe hyperbilirubinemia during combined therapy, which is an unreported side effect of DCV and ASV. A 78-year-old wom...

2014
Maurizia Brunetto Khurram Rana Gloria Taliani Eric Lawitz Christophe Hézode Patrick Marcellin Lawrence Serfaty David Cohen Subasree Srinivasan

Daclatasvir and Ribavirin for 12 Weeks in Patients Infected With HCV Genotype 1b Maurizia Brunetto, MD; Khurram Rana; Gloria Taliani; Eric Lawitz; Christophe Hézode; Patrick Marcellin; Lawrence Serfaty; David Cohen; Subasree Srinivasan; Liver Unit University Hospital of Pisa, Pisa, Italy; BristolMyers Squibb, Wallingford, CT; Azienda Ospedaliera Universitaria, Policlinico Umberto I, Roma, Italy...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید